Fondita European Micro Cap invests in small, high quality companies in Europe with a market cap of less than 800 million euros.
The fund invests in smaller niche players with a strong market position and a clear focus on long term growth and shareholder value creation. We find these companies within sectors such as industrial technology, medical technology, information technology and consumer related businesses. Among Europe’s smaller niche players are several family owned companies with good growth opportunities, sound balance sheets, and a high level of profitability. Smaller companies are also potential takeover candidates.
Fondita European Micro Cap is an actively managed fund with around 30 holdings and a long term investment horizon. The fund does not invest in shares of Eastern European companies.
The fund´s investment decisions take the environmental and social impacts of companies and governance into account, as well as risks related to this.
Fund facts
| Fund size | 53,6 MEUR |
| Fund unitholders | 236 |
| ISIN (A) | FI4000242847 |
| ISIN (B) | FI4000242854 |
| Legal structure | UCITS |
| Currency | EUR |
| Management fee | 2,00 % p.a. |
| Risk profile | 6/7 |
| SFDR Classification | Article 8 |
Top 5 Holdings
| Steico (DE) | 5,3 % |
| Medios (DE) | 4,5 % |
| Sdiptech (SE) | 4,5 % |
| Nexus (DE) | 4,4 % |
| PVA (DE) | 4,3 % |
Top 5 Countries
| Germany | 45 % |
| Great Britain | 16 % |
| Finland | 9 % |
| Sweden | 8 % |
| Italy | 7 % |
Return
| 1 month | 7,2 % |
| 3 months | 12,3 % |
| 6 months | 31,4 % |
| YTD | 43,0 % |
| 1 year | 66,8 % |
| 3 years | 67,9 % |
| since launch (7.3.2017) | 104,8 % |
| since launch p.a. | 17,3 % |
Sector Division
| Industrials | 31 % |
| Health Care | 23 % |
| Information Technology | 23 % |
| Consumer Discretionary | 11 % |
| Consumer Staples | 4 % |
| Communication Services | 3 % |
| Materials | 3 % |
| Cash | 2 % |
| Utilities | 1 % |
Top 10 Holdings
| Steico (DE) | 5,3 % |
| Medios (DE) | 4,5 % |
| Sdiptech (SE) | 4,5 % |
| Nexus (DE) | 4,4 % |
| PVA (DE) | 4,3 % |
| PharmaNutra (IT) | 4,3 % |
| Coltene (CH) | 4,0 % |
| Eckert & Ziegler (DE) | 4,0 % |
| Musti Group (FI) | 3,6 % |
| DiscoverIE (GB) | 3,4 % |
Country Division
| Germany | 45 % |
| Great Britain | 16 % |
| Finland | 9 % |
| Sweden | 8 % |
| Italy | 7 % |
| France | 5 % |
| Switzerland | 5 % |
| Netherlands | 2 % |
| Belgium | 1 % |
| Norway | 1 % |
| Denmark | 0 % |
Currency Exposure
| EUR | 69 % |
| GBP | 16 % |
| SEK | 8 % |
| CHF | 5 % |
| DKK | 0 % |
Risk Profile
- 1
- 2
- 3
- 4
- 5
- 6
- 7
Return
| 1 month | 7,2 % |
| 3 months | 12,3 % |
| 6 months | 31,4 % |
| YTD | 43,0 % |
| 1 year | 66,8 % |
| 3 years | 67,9 % |
| since launch (7.3.2017) | 104,8 % |
| since launch p.a. | 17,3 % |
Std Dev
| 3 years | 21,5 % |
| Launch | 19,0 % |
Sharpe
| 3 years | 0,93 |
| Launch | 0,95 |
Fees
| TER | 2,00 % |
| Subscription fee | 0,00 % |
| Redemption fee | 1,00 % |